Application Notes & Case Studies

31. Bleomycin-Induced Scleroderma Mouse Model For Preclinical Testing 3/27/2025

    Get an in-depth overview of the bleomycin-induced scleroderma model, detailing its key specifications and presenting significant findings observed following bleomycin administration in study animals.

32. Preclinical Evaluation Of Novel Drug Candidates Against SLE In NZB/W F1 Mouse Models 3/27/2025

    Explore how the well-established NZB/W F1 mouse model enables the evaluation of novel anti-SLE therapeutics, providing critical insights into disease mechanisms and treatment efficacy.

33. DSS-Induced IBD Mouse Model For Preclinical Drug Screening 3/27/2025

    Leverage our chemically induced murine model of Inflammatory Bowel Disease to accelerate your research on IBD and explore potential therapeutic interventions.

34. Propelling Glioblastoma Research: Orthotopic Model Solutions 3/27/2025

    Utilize our luciferase-based orthotopic GBM model to accelerate your research on glioblastoma therapies, offering precise tumor monitoring and non-invasive assessment of treatment efficacy.

35. Replicate Bioscience And Cytiva Collaborate To Deliver srRNA-LNP Vaccines 3/24/2025

    Discover how self-replicating RNA (srRNA) can revolutionize vaccine development with sustained protein expression, lower doses, and fewer side effects to advance next-gen RNA therapeutics.

36. Seamless Process Transfer Using An In Silico Bioreactor Scaling Tool 3/24/2025

    Transferring cell cultures between scales is challenging and error-prone. Discover a bioreactor scaling software that predicts optimal settings to enable efficient scale-up and progression to clinical studies.

37. Fast And Scalable Fc Quantitation In Supernatants 3/24/2025

    In biopharmaceutical development, the Fc PAIA Titer assay offers a fast, cost-effective, and automatable solution for high-throughput Fc quantification to enhance efficiency, support research, and accelerate production advancements.

38. Evaluating Compound Toxicity Effects On Healthy Intestinal Organoids 3/24/2025

    3D organoids enhance drug toxicity prediction and are crucial for anti-cancer drug development. Examine a method using 3D mouse intestinal organoids that aims to provide vital data on intestinal toxicity.

39. Cell Culture Automation Of The 3D Cancer Spheroid Assay 3/24/2025

    Discover how automated 3D cell culture methods enhance efficiency and consistency in high-throughput drug screening to accelerate the discovery of new anti-cancer therapies.

40. Studying The Spatial Architecture Of Glioblastoma 3/24/2025

    Explore how intra-tumor heterogeneity (ITH) impacts cancer progression and therapy resistance with advanced imaging platforms and custom antibody panels to reveal the spatial architecture of glioblastoma (GBM).